MedPath

Estradiol Pretreatment With Misoprostol in Second Trimester Miscarriage

Phase 2
Completed
Conditions
Miscarriage
Interventions
Drug: Placebo Oral Tablet
Registration Number
NCT03479879
Lead Sponsor
Ain Shams University
Brief Summary

To compare the effectiveness of estradiol pretreatment with misoprostol and vaginal misoprostol alone in induction of second trimestr miscarriage.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
200
Inclusion Criteria
  • Maternal age more than 18 years old (age of legal consent).
  • Gestational age between 12-26 weeks.
  • Hb level > 10 g/dL.
  • BMI between 25 kg/m2 and 35 kg/m2.
  • Missed abortion.
  • Living fetus with multiple congenital malformations incompatible with life.
  • PPROMS with drained liquor and parents are consenting for termination of pregnancy.
Exclusion Criteria
  • Maternal age less than 18 years old.
  • Gestational age less than 12 weeks or more than 26 weeks.
  • Hb level < 10 g/dL.
  • Scared uterus (previous myomectomy - cesarean section - hysterectomy and ruptured uterus).
  • Polyhydramnios.
  • Anencephaly.
  • Fibroid uterus.
  • BMI less than 25 kg/m2 and more than 35 kg/m2.
  • Coagulopathy.
  • Previous attempts for induction of abortion in the current pregnancy.
  • Allergy to misoprostol or estradiol.
  • Placenta previa.
  • Medical disorder that contraindicate induction of abortion (e.g. heart failure).

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Placebo + MisoprostolPlacebo Oral Tablet-
Placebo + MisoprostolMisoprostol-
Estradiol + MisoprostolEstradiol-
Estradiol + MisoprostolMisoprostol-
Primary Outcome Measures
NameTimeMethod
Duration of induction of abortion24 hours
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Ain Shams University Maternity Hospital

🇪🇬

Cairo, Egypt

© Copyright 2025. All Rights Reserved by MedPath